Corcept Therapeutics
CORT
CORT
239 hedge funds and large institutions have $2.24B invested in Corcept Therapeutics in 2022 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 91 increasing their positions, 78 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 225 → 239 (+14)
2.6% more ownership
Funds ownership: 79.03% → 81.63% (+2.6%)
8% less call options, than puts
Call options by funds: $8.13M | Put options by funds: $8.8M
Holders
239
Holding in Top 10
4
Calls
$8.13M
Puts
$8.8M
Top Buyers
| 1 | +$27M | |
| 2 | +$20.5M | |
| 3 | +$19.2M | |
| 4 |
BlackRock
New York
|
+$18.4M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$18M |
Top Sellers
| 1 | -$16.3M | |
| 2 | -$13.6M | |
| 3 | -$7.68M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$5.47M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$4.18M |